Phase 2 clinical trial of DS-1211 begins for individuals with Pseudoxanthoma Elasticum
A Phase 2 clinical trial has started of DS-1211 in individuals with Pseudoxanthoma Elasticum (PXE), a rare multisystem genetic disease ...
Tag: Pseudoxanthoma Elasticum
